Literature DB >> 21380935

Screening for acromegaly by application of a simple questionnaire evaluating the enlargement of extremities in adult patients seen at primary health care units.

Pedro Weslley Rosario1, Maria Regina Calsolari.   

Abstract

The objective of this study was to screen for acromegaly by application of a simple questionnaire in patients seen at primary health care units. A total of 17,000 patients of both genders >18 and <70 years seen by general practitioner were interviewed. Patients with known pituitary disease and pregnant women were excluded. A simple questionnaire was applied to the patients: Has your shoe size increased over the last 5 years? Did you have to change your wedding ring or ring over the last 5 years because it became tight? In one patient, the diagnosis of acromegaly was suspected by the physician. Among the remaining patients, 178 (1%) responded positively to one of the items of the questionnaire and were submitted to IGF-1 measurement. Five patients had persistently elevated IGF-1 and inadequate suppression of GH in the OGTT (without other conditions associated with GH or IGF-1 elevation). One of these patients presented a normal pituitary upon magnetic resonance imaging and adenoma was detected in the other four; two presented the typical facies and two others reported changes in physiognomy (confirmed by the comparison of photographs), in addition to the enlargement of extremities. The present investigation suggests a much higher prevalence of acromegaly in the adult population than that reported traditionally. We propose that screening based on phenotypic alterations is cost-effective since these changes occur early and almost universally in acromegaly and are uncommon in the general population.

Entities:  

Mesh:

Year:  2012        PMID: 21380935     DOI: 10.1007/s11102-011-0302-7

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  19 in total

Review 1.  Acromegaly and cancer: not a problem?

Authors:  S Melmed
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

2.  High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.

Authors:  Adrian F Daly; Martine Rixhon; Christelle Adam; Anastasia Dempegioti; Maria A Tichomirowa; Albert Beckers
Journal:  J Clin Endocrinol Metab       Date:  2006-09-12       Impact factor: 5.958

3.  Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population.

Authors:  Pedro Weslley Rosario
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

4.  Acromegaly without imaging evidence of pituitary adenoma.

Authors:  Russell R Lonser; Bogdan A Kindzelski; Gautam U Mehta; John A Jane; Edward H Oldfield
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

5.  Normal values of serum IGF-1 in adults: results from a Brazilian population.

Authors:  Pedro Weslley Rosario
Journal:  Arq Bras Endocrinol Metabol       Date:  2010

6.  Acromegaly with negative pituitary MRI and no evidence of ectopic source: the role of transphenoidal pituitary exploration?

Authors:  Sameera Daud; Amir H Hamrahian; Robert J Weil; Marwan Hamaty; Richard A Prayson; Leann Olansky
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

7.  Changing patterns in diagnosis and therapy of acromegaly over two decades.

Authors:  Lisa Nachtigall; Adriano Delgado; Brooke Swearingen; Hang Lee; Rahfa Zerikly; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2008-04-01       Impact factor: 5.958

8.  Growth hormone after oral glucose overload: revision of reference values in normal subjects.

Authors:  Pedro W S Rosário; Mariana S Furtado
Journal:  Arq Bras Endocrinol Metabol       Date:  2008-10

9.  Acromegaly. Clinical and biochemical features in 500 patients.

Authors:  S Ezzat; M J Forster; P Berchtold; D A Redelmeier; V Boerlin; A G Harris
Journal:  Medicine (Baltimore)       Date:  1994-09       Impact factor: 1.889

10.  Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed.

Authors:  Tirissa J Reid; Kalmon D Post; Jeffrey N Bruce; M Nabi Kanibir; Carlos M Reyes-Vidal; Pamela U Freda
Journal:  Clin Endocrinol (Oxf)       Date:  2009-05-16       Impact factor: 3.478

View more
  8 in total

Review 1.  The changing face of acromegaly--advances in diagnosis and treatment.

Authors:  Antônio Ribeiro-Oliveira; Ariel Barkan
Journal:  Nat Rev Endocrinol       Date:  2012-06-26       Impact factor: 43.330

2.  Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?

Authors:  Jessica A Brzana; Chris G Yedinak; Johnny B Delashaw; Hume S Gultelkin; David Cook; Maria Fleseriu
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

3.  Clinical manifestations and diagnosis of acromegaly.

Authors:  Gloria Lugo; Lara Pena; Fernando Cordido
Journal:  Int J Endocrinol       Date:  2012-02-01       Impact factor: 3.257

Review 4.  A practical approach to acromegaly management in Latin America.

Authors:  Marcello D Bronstein; Oscar D Bruno; Alin Abreu; Ruth Mangupli; Moisés Mercado
Journal:  Pituitary       Date:  2014-01       Impact factor: 4.107

Review 5.  Implementing a screening program for acromegaly in Latin America: necessity versus feasibility.

Authors:  Karina Danilowicz; Patricia Fainstein Day; Marcos P Manavela; Carlos Javier Herrera; María Laura Deheza; Gabriel Isaac; Ariel Juri; Debora Katz; Oscar D Bruno
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

6.  Prevalence of acromegaly in patients with symptoms of sleep apnea.

Authors:  Gemma Sesmilo; Eugenia Resmini; Marcel Sambo; Concepción Blanco; Fernando Calvo; Fernando Pazos; Pablo Fernández-Catalina; Purificación Martínez de Icaya; Concepción Páramo; Carmen Fajardo; Mónica Marazuela; Cristina Álvarez-Escolá; Juan Jose Díez; Verónica Perea
Journal:  PLoS One       Date:  2017-09-12       Impact factor: 3.240

7.  [Selective screening of patients with associated somatic diseases as a method of early detection of acromegaly].

Authors:  M B Antsiferov; V S Pronin; T M Alekseeva; O A Ionova; E Y Martynova; Yu E Poteshkin; N A Chubrova; K Y Zherebchikova
Journal:  Probl Endokrinol (Mosk)       Date:  2021-01-08

Review 8.  Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management.

Authors:  P Maffei; F Dassie; S Camerini; A Wennberg; M Adriani; B Martin; R Vettor
Journal:  J Endocrinol Invest       Date:  2022-03-23       Impact factor: 5.467

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.